News

Histofy, a leading biomedical technology  company developing transparent AI solutions for pathology, announces a partnership with Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications that assist in diagnosing cancer, enabling laboratories across the world to access Histofy’s cutting-edge AI tools. Birmingham, UK (14th February 2024) – Histofy is excited to […]

Histofy, a leading developer of transparent AI solutions for pathology, proudly introduces MitPro, its cutting-edge AI tool designed for advanced mitosis profiling—a critical component in cancer grading. Birmingham, UK (31st January 2024) –Histofy, a pioneering startup developing AI tools for pathology, unveils MitPro, a solution tailored for the comprehensive counting and profiling of mitosis. The

Histofy, a company specialising in developing transparent AI for pathology, today announces a project to develop an AI-powered system that provides precise quantification and profiling of cancer cells in growth overdrive, in order to enhance patient care. Birmingham, UK (20th March 2023) – Histofy, a UK-based startup developing transparent AI solutions for digital pathology, today announces

Histofy, a company specialising in AI for pathology, today announces £500K of funding to develop algorithms for endoscopic colon biopsy screening, helping to mitigate the worldwide pathology staffing crisis.  Birmingham, UK (10th March 2023) – Histofy, a spinout company from the University of Warwick, today announces it has joined hands with leading academic and clinical

Histofy today announces the signing of spinout agreement with the University of Warwick to commercialise cutting-edge artificial intelligence (AI) tools for pathology.  Birmingham, UK (8th March 2023) – Histofy, a medical technology company specialising in developing transparent AI models for pathology, has announced that it is now a spinout from the University of Warwick. The

Histofy, a Birmingham-based startup, has been founded to accelerate the transformation of cancer research and care with cutting-edge transparent artificial intelligence (AI) technology. Birmingham, UK (6th February 2023) – Histofy AI, a UK-based startup, has been founded by a team of world leading experts with an accumulated 40+ years of experience in the field of digital pathology